Bespak's nasal devices have been developed to consistently deliver accurate doses and minimise or eliminate intra- and inter-patient dosing variability. Our devices have been optimised using our proprietary in-vitro nasal cast modelling techniques that predict drug deposition within the nasal cavity.
This expertise has been used by Bespak and our development partners to better understand the properties and interrelation of three elements: the candidate drug formulation, the nasal anatomy / physiology and the characteristics of the delivery device.
Articles
Related links